Cyanotech (CYAN) and USANA Health Sciences (USNA) Head to Head Comparison
Cyanotech (NASDAQ:CYAN) and USANA Health Sciences (NYSE:USNA) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, dividends, risk, institutional ownership and valuation.
Volatility & Risk
Cyanotech has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500. Comparatively, USANA Health Sciences has a beta of 0.32, indicating that its stock price is 68% less volatile than the S&P 500.
13.3% of Cyanotech shares are held by institutional investors. Comparatively, 53.4% of USANA Health Sciences shares are held by institutional investors. 24.5% of Cyanotech shares are held by insiders. Comparatively, 42.5% of USANA Health Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Valuation & Earnings
This table compares Cyanotech and USANA Health Sciences’ gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Cyanotech||$34.12 million||0.54||$1.02 million||N/A||N/A|
|USANA Health Sciences||$1.19 billion||1.67||$126.22 million||$5.16||16.46|
USANA Health Sciences has higher revenue and earnings than Cyanotech.
This table compares Cyanotech and USANA Health Sciences’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|USANA Health Sciences||10.61%||30.49%||22.21%|
This is a breakdown of current recommendations and price targets for Cyanotech and USANA Health Sciences, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|USANA Health Sciences||0||0||2||0||3.00|
USANA Health Sciences has a consensus price target of $135.00, suggesting a potential upside of 58.91%. Given USANA Health Sciences’ higher probable upside, analysts clearly believe USANA Health Sciences is more favorable than Cyanotech.
USANA Health Sciences beats Cyanotech on 10 of the 11 factors compared between the two stocks.
Cyanotech Company Profile
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. The company's products include Hawaiian BioAstin natural astaxanthin, a dietary antioxidant, which is used as a human nutraceutical and functional food ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. Cyanotech Corporation sells its products as packaged consumer products through distributors, retailers, and online channels, as well as directly to consumers; and in bulk quantities to manufacturers, formulators, and distributors. The company was founded in 1983 and is headquartered in Kailua-Kona, Hawaii.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Sensébeautiful science products, such as personal care products that support healthy skin and hair through topical nourishment, moisturization, and protection; Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Receive News & Ratings for Cyanotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech and related companies with MarketBeat.com's FREE daily email newsletter.